GSK-3 inhibitors for the treatment of osteoporosis

Details for Australian Patent Application No. 2007222199 (hide)

Owner AstraZeneca AB

Inventors Bhat, Ratan; Berg, Anna-Lena

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007222199

PCT Pub. Number WO2007/102770

Priority 60/780,252 08.03.06 US

Filing date 6 March 2007

Wipo publication date 13 September 2007

International Classifications

A61K 31/497 (2006.01)

A61P 19/10 (2006.01) Drugs for skeletal disorders

Event Publications

4 September 2008 PCT application entered the National Phase

  PCT publication WO2007/102770 Priority application(s): WO2007/102770

16 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007222206-The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain

2007222178-Use of peptides for the control of radiation injury